OBJECTIVE: To evaluate the protective effects of an haemostatic ointment, at rhinosinusal mucosa level, on the development of bleeding in patients affected by epistaxis or with a positive clinical history for epistaxis in previous 7 days. PATIENTS AND METHODS: 100 patients affected by epistaxis or with a positive clinical history for epistaxis in previous 7 days. Patients underwent 15 days of treatment with an haemostatic ointment 2 times/day. RESULTS: The haemostatic ointment significantly reduced the percentage of patients affected by epistaxis and the number and severity of bleeding episodes (p < 0.001). 51% of patients experienced nasal obstruction during treatment, which persisted at the end of therapy only in 11% of them (p < 0.001). Nasal burning, nasal itching and rinorrhea involved less than 40% of patients in the first days of treatment and no more than 10% at the end of therapy (p < 0.001). CONCLUSIONS: The use of the haemostatic ointment in the treatment and in the prevention of not severe epistaxis acquire, in our opinion, a strong rationale.
Scheda prodotto non validato
Scheda prodotto in fase di analisi da parte dello staff di validazione
|Titolo:||[Haemostatic ointment efficacy in the treatment and prevention of epistaxis: a multi-centric study in 100 patients].|
|Citazione:||Passali, D., & Gruppo di Studio, E. (2005). [Haemostatic ointment efficacy in the treatment and prevention of epistaxis: a multi-centric study in 100 patients]. LA CLINICA TERAPEUTICA, 156(4), 139-143.|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto: